Challenges to defining a role for progesterone in breast cancer

Steroids

Volumn 73, Issue 9-10, 2008, Pages 914-921

  Lange, Carol A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Breast cancer; Estrogen; Progesterone; Protein kinases

Indexed keywords

PROGESTERONE;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; HORMONE ACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; ENDOMETRIUM; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MODELS, BIOLOGICAL; PROGESTERONE; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION;

EID: 44549088535     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.12.023     Document Type: Article

References (88)

1. Hewitt S.C., and Korach K.S. Progesterone action and responses in the alpha ERKO mouse. Steroids 65 10-11 (2000) 551-557
2. Feng Y., Manka D., Wagner K.U., and Khan S.A. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc Natl Acad Sci USA 104 37 (2007) 14718-14723
3. Mulac-Jericevic B., and Conneely O.M. Reproductive tissue selective actions of progesterone receptors. Reproduction 128 2 (2004) 139-146
4. Haslam S.Z., Counterman L.J., and Nummy K.A. Effects of epidermal growth factor, estrogen, and progestin on DNA synthesis in mammary cells in vivo are determined by the developmental state of the gland. J Cell Physiol 155 1 (1993) 72-78
5. Ruan W., Monaco M.E., and Kleinberg D.L. Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 146 3 (2005) 1170-1178
6. Ankrapp D.P., Bennett J.M., and Haslam S.Z. Role of epidermal growth factor in the acquisition of ovarian steroid hormone responsiveness in the normal mouse mammary gland. J Cell Physiol 174 2 (1998) 251-260
7. Robinson G.W., Hennighausen L., and Johnson P.F. Side-branching in the mammary gland: the progesterone-Wnt connection. Genes Dev 14 8 (2000) 889-894
8. Haslam S.Z., and Woodward T.L. Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res 5 4 (2003) 208-215
9. Li Y., and Rosen J.M. Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 10 1 (2005) 17-24
10. Wenger C.R., and Clark G.M. S-phase fraction and breast cancer-a decade of experience. Breast Cancer Res Treat 51 3 (1998) 255-265
11. Aupperlee M.D., Smith K.T., Kariagina A., and Haslam S.Z. Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development. Endocrinology 146 8 (2005) 3577-3588
12. Chlebowski R.T., Hendrix S.L., Langer R.D., Stefanick M.L., Gass M., Lane D., et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289 24 (2003) 3243-3253
13. Graham J.D., and Clarke C.L. Physiological action of progesterone in target tissues. Endocrinol Rev 18 4 (1997) 502-519
14. Haslam S.Z., Osuch J.R., Raafat A.M., and Hofseth L.J. Postmenopausal hormone replacement therapy: effects on normal mammary gland in humans and in a mouse postmenopausal model. J Mammary Gland Biol Neoplasia 7 1 (2002) 93-105
15. Kraus W.L., Montano M.M., and Katzenellenbogen B.S. Cloning of the rat progesterone receptor gene 5′-region and identification of two functionally distinct promoters. Mol Endocrinol 7 12 (1993) 1603-1616
16. Jacobsen B.M., Richer J.K., Schittone S.A., and Horwitz K.B. New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation. J Biol Chem 277 31 (2002) 27793-27800
17. Richer J.K., Jacobsen B.M., Manning N.G., Abel M.G., Wolf D.M., and Horwitz K.B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277 7 (2002) 5209-5218
18. Mulac-Jericevic B., Lydon J.P., DeMayo F.J., and Conneely O.M. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci USA 100 17 (2003) 9744-9749
19. Mulac-Jericevic B., Mullinax R.A., DeMayo F.J., Lydon J.P., and Conneely O.M. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 289 5485 (2000) 1751-1754
20. Wei L.L., Norris B.M., and Baker C.J. An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding. J Steroid Biochem Mol Biol 62 4 (1997) 287-297
21. Condon J.C., Hardy D.B., Kovaric K., and Mendelson C.R. Up-regulation of the progesterone receptor (PR)-C isoform in laboring myometrium by activation of nuclear factor-kappaB may contribute to the onset of labor through inhibition of PR function. Mol Endocrinol 20 4 (2006) 764-775
22. Pratt W.B., and Toft D.O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228 2 (2003) 111-133
23. Moore M.R., Zhou J.L., Blankenship K.A., Strobl J.S., Edwards D.P., and Gentry R.N. A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene. J Steroid Biochem Mol Biol 62 4 (1997) 243-252
24. Chalbos D., Chambon M., Ailhaud G., and Rochefort H. Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells. J Biol Chem 262 21 (1987) 9923-9926
25. Krusekopf S., Chauchereau A., Milgrom E., Henderson D., and Cato A.C. Co-operation of progestational steroids with epidermal growth factor in activation of gene expression in mammary tumor cells. J Steroid Biochem Mol Biol 40 1-3 (1991) 239-245
26. Lange C.A., Richer J.K., Shen T., and Horwitz K.B. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. J Biol Chem 273 47 (1998) 31308-31316
27. Richer J.K., Lange C.A., Wierman A.M., Brooks K.M., Tung L., Takimoto G.S., et al. Progesterone receptor variants found in breast cells repress transcription by wild-type receptors. Breast Cancer Res Treat 48 3 (1998) 231-241
28. Owen G.I., Richer J.K., Tung L., Takimoto G., and Horwitz K.B. Progesterone regulates transcription of the p21(WAF1) cyclin- dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 273 17 (1998) 10696-10701
29. Cui X., Lazard Z., Zhang P., Hopp T.A., and Lee A.V. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2. Oncogene 22 44 (2003) 6937-6941
30. Groshong S.D., Owen G.I., Grimison B., Schauer I.E., Todd M.C., Langan T.A., et al. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol 11 11 (1997) 1593-1607
31. Tseng L., Tang M., Wang Z., and Mazella J. Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts. DNA Cell Biol 22 10 (2003) 633-640
32. Proietti C., Salatino M., Rosemblit C., Carnevale R., Pecci A., Kornblihtt A.R., et al. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells. Mol Cell Biol 25 12 (2005) 4826-4840
33. Richer J.K., Lange C.A., Manning N.G., Owen G., Powell R., and Horwitz K.B. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity. J Biol Chem 273 47 (1998) 31317-31326
34. Boonyaratanakornkit V., Scott M.P., Ribon V., Sherman L., Anderson S.M., Maller J.L., et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8 2 (2001) 269-280
35. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17 7 (1998) 2008-2018
36. Saitoh M., Ohmichi M., Takahashi K., Kawagoe J., Ohta T., Doshida M., et al. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells. Endocrinology 146 11 (2005) 4917-4925
37. Shupnik M.A. Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation. Oncogene 23 48 (2004) 7979-7989
38. Migliaccio A., Castoria G., Di Domenico M., Ballare C., Beato M., and Auricchio F. The progesterone receptor/estradiol receptor association and the progestin-triggered S-phase entry. Ernst Schering Res Found Workshop 52 (2005) 39-54
39. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., et al. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 19 20 (2000) 5406-5417
40. Skildum A., Faivre E., and Lange C.A. Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol Endocrinol 19 2 (2005) 327-339
41. Faivre E., and Lange C. Progesterone receptors upregulate Wnt-1 to induce EGFR transactivation and c-Src-dependent sustained activation of Erk1/2 MAP Kinase in breast cancer cells. Mol Cell Biol. (2006)
42. Pierson-Mullany L.K., and Lange C.A. Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol Cell Biol 24 24 (2004) 10542-10557
43. Faivre E, Daniel AR, Hillard C, Lange CA. Progesterone receptor rapid signaling mediates Ser345 phosphorylation and tethering to Sp1 transcription factors. Mol Endocrinol 2008; in press.
44. Labriola L., Salatino M., Proietti C.J., Pecci A., Coso O.A., Kornblihtt A.R., et al. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells. Mol Cell Biol 23 3 (2003) 1095-1111
45. Qiu M., and Lange C.A. MAP kinases couple multiple functions of human progesterone receptors: degradation, transcriptional synergy, and nuclear association. J. Steroid Biochem. Mol. Biol. 85 (2003) 147-157
46. Daniel A.R., Faivre E.J., and Lange C.A. Phosphorylation-dependent antagonism of sumoylation de-represses progesterone receptor action in breast cancer cells. Mol Endocrinol (2007)
47. Byron S.A., Horwitz K.B., Richer J.K., Lange C.A., Zhang X., and Yee D. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. Br J Cancer 95 9 (2006) 1220-1228
48. Santen R., Jeng M.H., Wang J.P., Song R., Masamura S., McPherson R., et al. Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients. J Steroid Biochem Mol Biol 79 1-5 (2001) 115-125
49. Gee J.M., Robertson J.F., Ellis I.O., and Nicholson R.I. Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer. Int J Cancer 95 4 (2001) 247-254
50. Wilson G.R., Cramer A., Welman A., Knox F., Swindell R., Kawakatsu H., et al. Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. Br J Cancer 95 10 (2006) 1410-1414
51. Acosta J.J., Munoz R.M., Gonzalez L., Subtil-Rodriguez A., Dominguez-Caceres M.A., Garcia-Martinez J.M., et al. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol Endocrinol 17 11 (2003) 2268-2282
52. Mulloy R., Salinas S., Philips A., and Hipskind R.A. Activation of cyclin D1 expression by the ERK5 cascade. Oncogene 22 35 (2003) 5387-5398
53. Sakamoto K., Creamer B.A., Triplett A.A., and Wagner K.U. The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells. Mol Endocrinol 21 8 (2007) 1877-1892
54. Aupperlee M.D., and Haslam S.Z. Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 148 5 (2007) 2290-2300
55. Kariagina A., Aupperlee M.D., and Haslam S.Z. Progesterone receptor isoforms and proliferation in the rat mammary gland during development. Endocrinology 148 6 (2007) 2723-2736
56. Navarrete M.A., Maier C.M., Falzoni R., Quadros L.G., Lima G.R., Baracat E.C., et al. Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle. Breast Cancer Res 7 3 (2005) R306-R313
57. Soderqvist G., Isaksson E., von Schoultz B., Carlstrom K., Tani E., and Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 176 1 Pt 1 (1997) 123-128
58. Stute P., Wood C.E., Kaplan J.R., and Cline J.M. Cyclic changes in the mammary gland of cynomolgus macaques. Fertil Steril 82 Suppl 3 (2004) 1160-1170
59. Dabrosin C. Increase of free insulin-like growth factor-1 in normal human breast in vivo late in the menstrual cycle. Breast Cancer Res Treat 80 2 (2003) 193-198
60. Haslam S.Z. Experimental mouse model of hormonal therapy effects on the postmenopausal mammary gland. Breast Dis 24 (2005) 71-78
61. Soderqvist G. Effects of sex steroids on proliferation in normal mammary tissue. Ann Med 30 6 (1998) 511-524
62. Hofseth L.J., Raafat A.M., Osuch J.R., Pathak D.R., Slomski C.A., and Haslam S.Z. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 84 12 (1999) 4559-4565
63. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 14 (2004) 1701-1712
64. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362 9382 (2003) 419-427
65. Alkarain A., Jordan R., and Slingerland J. p27 deregulation in breast cancer: prognostic significance and implications for therapy. J Mammary Gland Biol Neoplasia 9 1 (2004) 67-80
66. Steeg P.S., and Zhou Q. Cyclins and breast cancer. Breast Cancer Res Treat 52 1-3 (1998) 17-28
67. Kumar S., Walia V., Ray M., and Elble R.C. p53 in breast cancer: mutation and countermeasures. Front Biosci 12 (2007) 4168-4178
68. Narayanan R., Adigun A.A., Edwards D.P., and Weigel N.L. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator. Mol Cell Biol 25 1 (2005) 264-277
69. Narayanan R., Edwards D.P., and Weigel N.L. Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity. Mol Cell Biol 25 8 (2005) 2885-2898
70. Pierson-Mullany L.K., Skildum A., Faivre E., and Lange C.A. Cross-talk between growth factor and progesterone receptor signaling pathways: implications for breast cancer cell growth. Breast Dis 18 (2003) 21-31
71. McGowan E.M., Russell A.J., Boonyaratanakornkit V., Saunders D.N., Lehrbach G.M., Sergio C.M., et al. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor. Cancer Res 67 18 (2007) 8942-8951
72. Rose-Hellekant T.A., and Sandgren E.P. Transforming growth factor alpha- and c-myc-induced mammary carcinogenesis in transgenic mice. Oncogene 19 8 (2000) 1092-1096
73. Ma Y., Katiyar P., Jones L.P., Fan S., Zhang Y., Furth P.A., et al. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Mol Endocrinol 20 1 (2006) 14-34
74. Poole A.J., Li Y., Kim Y., Lin S.C., Lee W.H., and Lee E.Y. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 314 5804 (2006) 1467-1470
75. Lange C.A., Gioeli D., Hammes S.R., and Marker P.C. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu Rev Physiol 69 (2007) 171-199
76. Daniel A.R., Qiu M., Faivre E.J., Ostrander J.H., Skildum A., and Lange C.A. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth. Steroids 72 2 (2007) 188-201
77. Shen T., Horwitz K.B., and Lange C.A. Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol 21 18 (2001) 6122-6131
78. McGowan E.M., and Clarke C.L. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells. Mol Endocrinol 13 10 (1999) 1657-1671
79. Jacobsen B.M., Schittone S.A., Richer J.K., and Horwitz K.B. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology. Mol Endocrinol 19 3 (2005) 574-587
80. Graham J.D., Yeates C., Balleine R.L., Harvey S.S., Milliken J.S., Bilous A.M., et al. Characterization of progesterone receptor A and B expression in human breast cancer. Cancer Res 55 21 (1995) 5063-5068
81. Jacobsen B.M., Richer J.K., Sartorius C.A., and Horwitz K.B. Expression profiling of human breast cancers and gene regulation by progesterone receptors. J Mammary Gland Biol Neoplasia 8 3 (2003) 257-268
82. Hissom J.R., and Moore M.R. Progestin effects on growth in the human breast cancer cell line T-47D-possible therapeutic implications. Biochem Biophys Res Commun 145 2 (1987) 706-711
83. Musgrove E.A., Lee C.S., and Sutherland R.L. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes. Mol Cell Biol 11 10 (1991) 5032-5043
84. Lange C.A., Richer J.K., and Horwitz K.B. Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13 6 (1999) 829-836
85. Lange C.A. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?. Mol Endocrinol 18 2 (2004) 269-278
86. Moore M.R., Spence J.B., Kiningham K.K., and Dillon J.L. Progestin inhibition of cell death in human breast cancer cell lines. J Steroid Biochem Mol Biol 98 4-5 (2006) 218-227
87. Sartorius C.A., Harvell D.M., Shen T., and Horwitz K.B. Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth. Cancer Res 65 21 (2005) 9779-9788
88. Woodward T.L., Lu H., and Haslam S.Z. Laminin inhibits estrogen action in human breast cancer cells. Endocrinology 141 8 (2000) 2814-2821